Evidence map›Paper›PMID 41522604›Full record

ArticleCyborg and bionic systems (Washington, D.C.)2026

Nano-Immunotherapy Synergizing Ferroptosis and STING Activation in Metastatic Bladder Cancer.

Hang Huang, Fangdie Ye, Tianyue Liu, Junkai Hong, Haoran Jiang, Zijian Chen, Qimeng Li, Wei Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cyborg and bionic systems (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hang HuangDepartment of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Fangdie YeDepartment of Urology, Huashan Hospital, Fudan University, Shanghai 200040, China.
Tianyue LiuDepartment of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Junkai HongDepartment of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Haoran JiangDepartment of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Zijian ChenDepartment of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Qimeng LiDepartment of Urology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Wei ChenDepartment of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41522604
PMCPMC12783508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.